Profil bibliographique

Marcel Martin

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

17Publications signalées

323Citations signalées

3Affiliations récentes

Institutions déclarées

Johannes Gutenberg University Mainz Tetramer Technologies (United States)IT University of Copenhagen

Domaines associés

Peptidase Inhibition and AnalysisRadiopharmaceutical Chemistry and ApplicationsCardiac Structural Anomalies and RepairNeuroendocrine Tumor Research AdvancesNeuropeptides and Animal Physiology

Publications récentes

2026 conference-abstractOpenAlex

Abstract 5822: Efficacy of targeted radionuclide therapy Using 131I-FAPi dimers labeled via tetrazine ligation in a human glioblastoma xenograft model

Umberto Maria Battisti, Marcel Martin, Vladimir Shalgunov, Filipe Elvas et autres

0 citationsCancer Research

Accès ouvert 2026 articleOpenAlex

THERANOSTIC POTENTIAL OF DOTAGA.GLU.(FAPI)2 AND DO3A.GLU.(FAPI)2 WITH HUMAN DOSIMETRY EXTRAPOLATION FOR THEIR 177-LUTETIUM AND 161-TERBIUM RADIOLABELED ANALOGUES

Adrianna Bilinska, Naveen Kumar, Silvano Gnesin, Elena Menéndez et autres

0 citationsEANM Innovation

Accès ouvert 2026 articleOpenAlex

Alpha Therapy Beyond TOC and TATE—Production, Quality Control, and In-Human Results for the SSTR2 Antagonist DOTA-LM3

Lukas Greifenstein, Marcel Martin, Sarah Stephan, Aleksandr Eismant et autres

1 citationPharmaceuticals

2025 articleOpenAlex

Preclinical Comparison of Two Dimeric FAP Inhibitors, DOTAGA.Glu(FAPi)2 and DO3A.Glu(FAPi)2, Labeled with Gallium-68 and Lutetium-177 for Theranostic Tumor Stroma Targeting

Adrianna Bilinska, Tilman Läppchen, Naveen Kumar, Elena Menéndez et autres

0 citationsNuclear Medicine and Biology

2025 articleOpenAlex

Optimizing FAP Radiopharmaceuticals: Key Insights from a Dose Escalation Study

Adrianna Bilinska, Tilman Läppchen, Elena Menéndez, Marcel Martin et autres

0 citationsNuclear Medicine and Biology

Accès ouvert 2025 articleOpenAlex

Preclinical evaluation of DOTAGA.Glu.(FAPI)2 and DO3A.Glu.(FAPI)2 as theranostics with human dosimetry extrapolation to lutetium-177 and terbium-161 analogs

Adrianna Bilinska, Naveen Kumar, Silvano Gnesin, Tilman Läppchen et autres

5 citationsEuropean Journal of Nuclear Medicine and Molecular Imaging

Accès ouvert 2025 articleOpenAlex

Improved FAPI-radiopharmaceutical pharmacokinetics from the perspectives of a dose escalation study

Adrianna Bilinska, Sanjana Ballal, Chandrasekhar Bal, Tilman Läppchen et autres

17 citationsEuropean Journal of Nuclear Medicine and Molecular Imaging

2025 articleOpenAlex

Head-to-Head Comparison Between [68Ga]Ga-DOTA.SA.FAPi And [18F]F-FDG PET/CT Imaging in Patients With Sarcoma

Mohammad Sakir, Sanjana Ballal, Sameer Rastogi, Madhav Prasad Yadav et autres

10 citationsClinical Nuclear Medicine

Accès ouvert 2025 articleOpenAlex

Long-Term Outcomes in Radioiodine-Resistant Follicular Cell-Derived Thyroid Cancers Treated with [ 177 Lu]Lu-DOTAGA.FAPi Dimer Therapy

Sanjana Ballal, Madhav Prasad Yadav, Swayamjeet Satapathy, Frank Roesch et autres

23 citationsThyroid

2023 articleOpenAlex

Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment

Madhav Prasad Yadav, Sanjana Ballal, Marcel Martin, Frank Roesch et autres

68 citationsEuropean Journal of Nuclear Medicine and Molecular Imaging

2023 articleOpenAlex

Head-to-head comparison of [68Ga]Ga-DOTA.SA.FAPi with [18F]F-FDG PET/CT in radioiodine-resistant follicular-cell derived thyroid cancers

Sanjana Ballal, Madhav Prasad Yadav, Frank Roesch, Swayamjeet Satapathy et autres

34 citationsEuropean Journal of Nuclear Medicine and Molecular Imaging

Accès ouvert 2023 articleOpenAlex

[177Lu]Lu-DOTAGA.Glu.(FAPi)2 Radionuclide Therapy: a New Treatment Option for Patients with Glioblastoma Multiforme

Sanjana Ballal, Madhav Prasad Yadav, Shobhana Raju, Frank Roesch et autres

19 citationsNuclear Medicine and Molecular Imaging

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.